What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Nabi Aims at Nicotine Addiction with Phase III NicVAX Study      4-Nov-09 06:17 am    
WASHINGTON - With $10 million in stimulus funds in hand, Nabi Biopharmaceuticals has started a 1,000-patient Phase III trial of NicVAX (nicotine conjugate vaccine), which is the first time a vaccine to treat nicotine addiction has made it to late-stage testing.

http://www.therapeuticsdaily.com/news/ar...
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

sock_monkey...

47/Male
3rd stone f...


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Nabi Aims at Nicotine Addiction with Phase III NicVAX S...
sock_monkey... Not rated 4-Nov-09 06:17 am  
 
Public-private partnerships work very well, said F...
pumpjackie3... Rate it 4-Nov-09 07:27 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Nabi Biopharmaceuticals (NABI)

Chart for Nabi Biopharmaceuticals (NABI)
On Nov 25: 4.93 Up 0.03 (0.61%)
Symbol Lookup